双特异性阿帕特马-药物结合物可选择性地消除恶性血液细胞,用于治疗急性髓性白血病
Xiaodong Li1, Jiacheng Dai2, Yuenan Shi2
1Zhejiang Cancer Hospital, The Key Laboratory of Zhejiang Province for Nucleic Acids, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
Langmuir : the ACS journal of surfaces and colloids
|January 22, 2025
概括
这项研究开发了一种新型双特异性阿帕特默-药物联合体,以向急性髓性白血病 (AML) 细胞. 这种新疗法有效地消除白血病细胞,同时保留健康细胞,为AML治疗提供了有前途的进展.
科学领域:
- 生物技术是生物技术.
- 瘤学 在瘤学方面.
- 免疫疗法是一种免疫疗法.
背景情况:
- 表面抗原定向免疫疗法对急性髓性白血病 (AML) 具有前景,但由于单一向疗法所产生的耐药性,它面临着挑战.
- 在AML中异质抗原表达需要更有效的治疗策略来改善患者的治疗结果.
研究的目的:
- 设计和评估一种双特异性阿巴美尔-药物合物,以增强针对性和有效性对抗AML细胞.
- 克服与AML目前的单针对性免疫疗法相关的耐药性机制.
主要方法:
- 使用细胞-SELEX. 开发了针对AML细胞上的CD117和CD71表面抗原的双特异性吸收体.
- 与单甲基奥里斯塔丁F (MMAF) 结合的阿帕特马,以产生阿帕特马-药物结合物.
- 在实验室中评估结合剂对AML细胞系和AML患者初级样本的疗效.
主要成果:
- 双特异性阿帕特马-MMAF合物证明有效地杀死具有不同CD117和CD71表达水平的AML细胞系.
- 结合剂选择性地从患者骨髓样本中消除了AML初级细胞.
- 同样样本中的健康淋巴细胞不受治疗的影响.
结论:
- 双特异性阿巴美尔-药物合物代表了针对人类AML细胞的可行概念验证.
- 这种方法有望通过克服耐药性和增强特异性来改善AML治疗策略和患者的治疗结果.
更多相关视频
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.2K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K